Neuropsychiatric drug development: Perspectives on the current landscape, opportunities and potential future directions DOI Creative Commons
Simon Loïodice, Fulvio D’Acquisto,

Pim Drinkenburg

и другие.

Drug Discovery Today, Год журнала: 2024, Номер 30(1), С. 104255 - 104255

Опубликована: Ноя. 29, 2024

Язык: Английский

Naturalistic computational psychiatry: How to get there? DOI Open Access
Lena Palaniyappan, Alban Voppel, Holly Wei

и другие.

Journal of Psychiatry and Neuroscience, Год журнала: 2025, Номер 50(1), С. E67 - E72

Опубликована: Фев. 7, 2025

> Consider the practical effects of objects your conception. Then, conception those is whole object. — Charles Sanders Peirce[1][1] Each us has an individual mental phenomenon that defines us. Some our differences and similarities

Язык: Английский

Процитировано

0
What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry? DOI
S Hashimoto, Atsushi Fujimoto, Catherine Elorette

и другие.

Neuropsychopharmacology, Год журнала: 2024, Номер 50(1), С. 184 - 195

Опубликована: Авг. 28, 2024

Язык: Английский

Процитировано

2
From palm to practice: prescription digital therapeutics for mental and brain health at the National Institutes of Health DOI Creative Commons

Michele Ferrante,

Layla Esposito,

Luke E. Stoeckel

и другие.

Frontiers in Psychiatry, Год журнала: 2024, Номер 15

Опубликована: Сен. 10, 2024

Prescription Digital Therapeutics (PDTs) are emerging as promising tools for treating and managing mental brain health conditions within the context of daily life. This commentary distinguishes PDTs from other Software Medical Devices (SaMD) explores their integration into treatments. We focus on research programs support National Institutes Health (NIH), discussing PDT supported by NIH's Institute Child Development (NICHD), Mental (NIMH), Aging (NIA). present a hierarchical natural language processing topic analysis NIH-funded digital therapeutics projects. delineate landscape across different disorders while highlighting opportunities challenges. Additionally, we discuss foundation PDTs, unique therapeutic approaches they employ, potential strategies to improve validity, reliability, safety, effectiveness. Finally, address collaborations necessary propel field forward, ultimately enhancing patient care through innovative solutions.

Язык: Английский

Процитировано

0
Characterizing Behavioral Dynamics in Bipolar Disorder with Computational Ethology DOI Creative Commons
Zhanqi Zhang, Chien Chou,

Holden Rosberg

и другие.

medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Ноя. 15, 2024

New technologies for the quantification of behavior have revolutionized animal studies in social, cognitive, and pharmacological neurosciences. However, comparable understanding human behavior, especially psychiatry, are lacking. In this study, we utilized data-driven machine learning to analyze natural, spontaneous open-field behaviors from people with euthymic bipolar disorder (BD) non-BD participants. Our computational paradigm identified representations distinct sets actions (

Язык: Английский

Процитировано

0
Neuropsychiatric drug development: Perspectives on the current landscape, opportunities and potential future directions DOI Creative Commons
Simon Loïodice, Fulvio D’Acquisto,

Pim Drinkenburg

и другие.

Drug Discovery Today, Год журнала: 2024, Номер 30(1), С. 104255 - 104255

Опубликована: Ноя. 29, 2024

Язык: Английский

Процитировано

0